by mariel | Oct 28, 2025 | Portfolio News
Novartis completed its acquisition of Tourmaline Bio following the previously announced all-cash agreement at $48/share. by mariel | Oct 17, 2025 | Portfolio News
Nalu Medical agreed to be acquired by Boston Scientific for $533 million in cash (excluding Boston Scientific’s existing strategic investments). by mariel | Oct 16, 2025 | Portfolio News
Veradermics closed an oversubscribed $150 million Series C financing led by SR One to fund Phase 3/registrational work for its lead program. by mariel | Oct 8, 2025 | Portfolio News
Zenas announced a license agreement for global development/commercialization rights to orelabrutinib for MS and additional autoimmune assets; Phase 3 activity in progressive MS was underway/initiating. by mariel | Oct 1, 2025 | Portfolio News
Somatus reported results from a new study showing a statistically significant reduction in mortality for kidney disease patients, reinforcing outcomes from its care model.